Fraudulent pharmaceuticals: the legacy of anti-counterfeit packaging

Brexit
As a result of its departure from the EU and the ongoing Covid-19 pandemic, the UK is in need of new solutions to protect its supply chains from counterfeit medicines. Credit: Shutterstock.